No Data
No Data
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 4/16)
[Good Material] ――――――――――■Studio Alice [Tokyo Stock Exchange P] March sales increased 4.5% from the same month last year. ■Part of the “wcloset” brand store and EC related business assets etc. were taken over from Pal Group Holdings [Tokyo Stock Exchange P] Wears. ■Jade Group [TSE G] buy up to 575,000 shares (1 billion yen in value), which is 5.36% of the number of issued shares (excluding company shares)
Seraku's Fiscal H1 Attributable Profit Down 10% Amid Higher Spending
Seraku (TYO:6199) posted a 10% drop in profit attributable to owners in the fiscal first half after higher selling, general, and administrative expenses offset a 6.5% jump in net sales. The informatio
Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen
Astellas Pharmaceuticals <4503> announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] <8233>Takashimaya Full Year | <6432>Takeuchi Production
Seraku Sees FY Net Y1.50B
Seraku Sees FY Net Y1.50B
Seraku 1H Net Y769.00M Vs Net Y855.00M
Seraku 1H Net Y769.00M Vs Net Y855.00M
Bic Camera, Money Forward, Ryohin Keikaku, Takashimaya (12 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/12 (Fri) <1401>mbs <1407>West HD<1418>Interlife <1434>JESCOHD<2153>Ejay HD <2168>Pasona G<2305>Studio Alice <2379>dip
No Data